Universal Ebitda vs Total Revenue Analysis

601231 Stock

15.29 0.66 4.51%

Universal Scientific financial indicator trend analysis is much more than just breaking down Universal Scientific prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Universal Scientific is a good investment. Please check the relationship between Universal Scientific Ebitda and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ebitda vs Total Revenue

Ebitda vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Universal Scientific Ebitda account and Total Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between Universal Scientific's Ebitda and Total Revenue is 0.77. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Universal Scientific Industrial, assuming nothing else is changed. The correlation between historical values of Universal Scientific's Ebitda and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Universal Scientific Industrial are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Ebitda i.e., Universal Scientific's Ebitda and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.77

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ebitda

Total Revenue

Total revenue comprises all receipts Universal Scientific generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Universal Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Universal Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 718.4 M. The current year's Tax Provision is expected to grow to about 277.3 M

	2021	2022	2023	2024 (projected)
Operating Income	2.2B	3.4B	2.5B	1.3B
Total Revenue	55.3B	68.5B	60.8B	32.9B

Operating Income Total Revenue

Universal Scientific fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Short Term Investments	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		-0.01	0.87	0.98	0.88	0.88	0.97	0.76	0.81	0.97	0.98	0.77	0.99	0.87	0.78	0.84	0.68	0.11	0.94	0.74	-0.88	0.75	0.96	0.88	0.91	0.86
Other Current Liab	-0.01		-0.23	-0.05	-0.16	-0.23	0.1	-0.31	0.17	0.14	-0.04	-0.3	0.02	-0.12	0.06	-0.21	0.35	0.05	-0.26	-0.34	0.13	-0.47	-0.15	-0.01	-0.16	0.09
Total Current Liabilities	0.87	-0.23		0.86	0.97	0.99	0.84	0.94	0.67	0.84	0.85	0.94	0.87	0.93	0.66	0.97	0.48	0.09	0.91	0.89	-0.91	0.91	0.93	0.81	0.89	0.83
Total Stockholder Equity	0.98	-0.05	0.86		0.84	0.88	0.95	0.79	0.87	0.93	0.94	0.74	0.95	0.8	0.84	0.81	0.55	0.23	0.93	0.71	-0.88	0.76	0.92	0.89	0.85	0.79
Other Liab	0.88	-0.16	0.97	0.84		0.96	0.86	0.89	0.65	0.85	0.85	0.91	0.89	0.95	0.63	0.97	0.58	-0.02	0.88	0.82	-0.88	0.81	0.93	0.79	0.92	0.84
Retained Earnings	0.88	-0.23	0.99	0.88	0.96		0.86	0.95	0.7	0.85	0.85	0.92	0.86	0.9	0.71	0.94	0.46	0.14	0.91	0.86	-0.93	0.9	0.92	0.85	0.86	0.82
Accounts Payable	0.97	0.1	0.84	0.95	0.86	0.86		0.71	0.82	0.99	0.95	0.74	0.97	0.83	0.83	0.78	0.71	0.11	0.88	0.64	-0.88	0.67	0.92	0.91	0.84	0.88
Cash	0.76	-0.31	0.94	0.79	0.89	0.95	0.71		0.68	0.67	0.68	0.86	0.72	0.79	0.66	0.9	0.21	0.24	0.83	0.83	-0.86	0.88	0.8	0.75	0.75	0.62
Other Assets	0.81	0.17	0.67	0.87	0.65	0.7	0.82	0.68		0.76	0.75	0.48	0.76	0.55	0.92	0.61	0.4	0.5	0.66	0.47	-0.7	0.53	0.66	0.76	0.57	0.58
Net Receivables	0.97	0.14	0.84	0.93	0.85	0.85	0.99	0.67	0.76		0.96	0.75	0.97	0.85	0.76	0.78	0.76	0.05	0.88	0.67	-0.87	0.67	0.93	0.9	0.86	0.92
Inventory	0.98	-0.04	0.85	0.94	0.85	0.85	0.95	0.68	0.75	0.96		0.74	0.98	0.88	0.72	0.81	0.76	0.07	0.91	0.75	-0.83	0.75	0.96	0.82	0.9	0.9
Other Current Assets	0.77	-0.3	0.94	0.74	0.91	0.92	0.74	0.86	0.48	0.75	0.74		0.77	0.88	0.51	0.91	0.39	-0.07	0.86	0.85	-0.8	0.85	0.87	0.71	0.84	0.76
Total Liab	0.99	0.02	0.87	0.95	0.89	0.86	0.97	0.72	0.76	0.97	0.98	0.77		0.9	0.73	0.84	0.75	0.02	0.93	0.74	-0.86	0.73	0.97	0.86	0.94	0.89
Intangible Assets	0.87	-0.12	0.93	0.8	0.95	0.9	0.83	0.79	0.55	0.85	0.88	0.88	0.9		0.51	0.96	0.7	-0.14	0.88	0.89	-0.83	0.82	0.95	0.73	0.96	0.9
Common Stock	0.78	0.06	0.66	0.84	0.63	0.71	0.83	0.66	0.92	0.76	0.72	0.51	0.73	0.51		0.54	0.34	0.46	0.66	0.44	-0.76	0.54	0.64	0.82	0.52	0.56
Property Plant Equipment	0.84	-0.21	0.97	0.81	0.97	0.94	0.78	0.9	0.61	0.78	0.81	0.91	0.84	0.96	0.54		0.52	-0.02	0.87	0.9	-0.83	0.86	0.91	0.71	0.92	0.8
Long Term Debt	0.68	0.35	0.48	0.55	0.58	0.46	0.71	0.21	0.4	0.76	0.76	0.39	0.75	0.7	0.34	0.52		-0.21	0.5	0.4	-0.5	0.29	0.66	0.49	0.68	0.79
Short Term Investments	0.11	0.05	0.09	0.23	-0.02	0.14	0.11	0.24	0.5	0.05	0.07	-0.07	0.02	-0.14	0.46	-0.02	-0.21		0.02	0.05	-0.22	0.14	-0.02	0.12	-0.18	-0.16
Net Tangible Assets	0.94	-0.26	0.91	0.93	0.88	0.91	0.88	0.83	0.66	0.88	0.91	0.86	0.93	0.88	0.66	0.87	0.5	0.02		0.83	-0.88	0.86	0.97	0.85	0.93	0.81
Other Stockholder Equity	0.74	-0.34	0.89	0.71	0.82	0.86	0.64	0.83	0.47	0.67	0.75	0.85	0.74	0.89	0.44	0.9	0.4	0.05	0.83		-0.79	0.95	0.84	0.62	0.83	0.72
Deferred Long Term Liab	-0.88	0.13	-0.91	-0.88	-0.88	-0.93	-0.88	-0.86	-0.7	-0.87	-0.83	-0.8	-0.86	-0.83	-0.76	-0.83	-0.5	-0.22	-0.88	-0.79		-0.83	-0.9	-0.92	-0.8	-0.77
Short Long Term Debt	0.75	-0.47	0.91	0.76	0.81	0.9	0.67	0.88	0.53	0.67	0.75	0.85	0.73	0.82	0.54	0.86	0.29	0.14	0.86	0.95	-0.83		0.84	0.72	0.78	0.7
Total Current Assets	0.96	-0.15	0.93	0.92	0.93	0.92	0.92	0.8	0.66	0.93	0.96	0.87	0.97	0.95	0.64	0.91	0.66	-0.02	0.97	0.84	-0.9	0.84		0.85	0.96	0.9
Short Term Debt	0.88	-0.01	0.81	0.89	0.79	0.85	0.91	0.75	0.76	0.9	0.82	0.71	0.86	0.73	0.82	0.71	0.49	0.12	0.85	0.62	-0.92	0.72	0.85		0.73	0.8
Non Current Assets Total	0.91	-0.16	0.89	0.85	0.92	0.86	0.84	0.75	0.57	0.86	0.9	0.84	0.94	0.96	0.52	0.92	0.68	-0.18	0.93	0.83	-0.8	0.78	0.96	0.73		0.84
Non Currrent Assets Other	0.86	0.09	0.83	0.79	0.84	0.82	0.88	0.62	0.58	0.92	0.9	0.76	0.89	0.9	0.56	0.8	0.79	-0.16	0.81	0.72	-0.77	0.7	0.9	0.8	0.84

Click cells to compare fundamentals

Universal Scientific Account Relationship Matchups

Universal Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	21.9B	31.0B	35.9B	38.6B	39.3B	20.0B
Other Current Liab	644.6M	826.9M	1.3B	3.7M	3.9M	3.7M
Total Current Liabilities	10.9B	14.9B	17.6B	18.7B	21.2B	22.3B
Total Stockholder Equity	10.3B	12.1B	13.1B	15.7B	17.0B	8.6B
Other Liab	144.8M	223.2M	560.4M	516.6M	594.1M	623.8M
Retained Earnings	6.5B	7.9B	8.6B	10.3B	11.2B	11.7B
Accounts Payable	7.6B	11.2B	11.5B	11.1B	10.6B	6.6B
Cash	6.1B	6.3B	6.0B	7.7B	11.2B	11.8B
Other Assets	608.4M	535.1M	647.7M	690.9M	794.5M	404.0M
Net Receivables	7.4B	10.5B	12.5B	11.1B	10.0B	6.6B
Inventory	4.3B	6.8B	9.0B	10.9B	8.3B	4.4B
Other Current Assets	351.4M	508.5M	588.2M	599.9M	838.4M	880.3M
Total Liab	11.6B	18.9B	22.8B	22.8B	22.2B	11.4B
Intangible Assets	137.3M	290.4M	453.5M	415.1M	368.3M	386.7M
Property Plant Equipment	1.6B	2.5B	4.0B	4.8B	5.5B	5.8B
Net Tangible Assets	10.1B	10.9B	12.1B	13.9B	15.9B	10.9B
Other Stockholder Equity	(44.3M)	6.9M	(91.2M)	326.3M	375.2M	394.0M
Deferred Long Term Liab	301.2M	286.1M	250.5M	227.6M	204.8M	227.5M
Short Long Term Debt	1.8B	375.3M	2.5B	4.5B	4.4B	4.6B
Total Current Assets	18.2B	24.6B	28.5B	30.9B	31.0B	23.3B
Non Current Assets Total	3.7B	6.4B	7.4B	7.7B	8.3B	5.6B
Non Currrent Assets Other	75.3M	89.8M	136.8M	124.6M	68.3M	81.6M
Non Current Liabilities Total	747.9M	4.0B	5.2B	4.1B	1.0B	972.6M
Non Current Liabilities Other	5.0M	16.3M	61.3M	11.0M	74.9M	78.6M
Common Stock Shares Outstanding	2.2B	2.2B	2.2B	2.2B	2.2B	2.4B
Net Invested Capital	12.1B	15.4B	19.8B	23.6B	21.4B	17.7B
Net Working Capital	7.3B	9.7B	10.9B	12.1B	9.8B	10.0B
Capital Stock	2.2B	2.2B	2.2B	2.2B	2.2B	2.4B

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Universal Stock

Balance Sheet is a snapshot of the financial position of Universal Scientific at a specified time, usually calculated after every quarter, six months, or one year. Universal Scientific Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Universal Scientific and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Universal currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Universal Ebitda vs Total Revenue Analysis

Ebitda vs Total Revenue

Ebitda vs Total Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Total Revenue

Universal Scientific fundamental ratios Correlations

Universal Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Universal Scientific fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Universal Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Current Liabilities
Net Receivables	+ 0.99	Accounts Payable
Total Stockholder Equity	+ 0.98	Total Assets
Inventory	+ 0.98	Total Assets
Total Liab	+ 0.98	Inventory

Deferred Long Term Liab	- 0.93	Retained Earnings
Short Term Debt	- 0.92	Deferred Long Term Liab
Deferred Long Term Liab	- 0.91	Total Current Liabilities
Total Current Assets	- 0.9	Deferred Long Term Liab
Deferred Long Term Liab	- 0.88	Net Tangible Assets
Deferred Long Term Liab	- 0.88	Accounts Payable